9 mm part-solid nodule with 4 mm solid component — Lung-RADS 4A; growth from baseline.
Carmen is squarely in the screening-eligible cohort. Her 30-pack-year exposure (>=20) and quit-window (<=15 yrs) put her at high relative risk; 3rd-annual LDCT is the standard pathway.
9 mm part-solid nodule in the right upper lobe with a 4 mm solid component. Has grown from a 6 mm pure-ground-glass on baseline CT 24 months ago — concerning for adenocarcinoma in situ progressing to minimally invasive adenocarcinoma.
Carmen's first LDCT showed a 6 mm pure-ground-glass nodule the radiologist coded Lung-RADS 2 (benign-appearing). On her 3rd annual scan, OCTON's longitudinal compare flagged 50% diameter growth and a new 4 mm solid component — Lung-RADS 4A. Wedge resection found AIS with a 3 mm focus of invasion (MIA, T1mi N0 M0, Stage IA1). 5-year disease-specific survival for resected MIA: 100%.
Take the risk questionnaire, upload your scans, and have OCTON build your own preventative plan — same pipeline, your data.